WallStreetZenWallStreetZen

NASDAQ: ONC
Beone Medicines Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Beone Medicines revenue was $4.18B for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $1.1B, down 0.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ONC annual revenue was $3.8B, with 55% growth year-over-year.

ONC past revenue growth

How has ONC's revenue growth performed historically?

Company
51.16%
Industry
1,361.15%
Market
34.96%
ONC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ONC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ONC's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ONC revenue history

Current Revenue
$4.2B
Current Earnings
-$392.4M
Current Profit Margin
-9.4%

Be the first to know when ONC announces revenue.

ONC Revenue History By Year

ONC Yearly RevenueONC RevenueONC ChangeONC Revenue Growth
2024-12-31$3.81B$1.35B+54.96%
2023-12-31$2.46B$1.04B+73.65%
2022-12-31$1.42B$239.64M+20.37%
2021-12-31$1.18B$867.41M+280.83%
2020-12-31$308.87M-$119.34M-27.87%
2019-12-31$428.21M$229.99M+116.03%
2018-12-31$198.22M-$40.17M-16.85%
2017-12-31$238.39M$237.32M+22,179.16%
2016-12-31$1.07M-$7.75M-87.86%
2015-12-31$8.82M-$4.22M-32.37%
2014-12-31$13.04M$1.89M+16.93%
2013-12-31$11.15MN/AN/A

1 of 1

Beone Medicines Revenue FAQ

What was ONC's revenue last quarter?

Beone Medicines (NASDAQ: ONC) reported Q1 2025 revenue of $1.12 billion up 48.64% year over year. In the same quarter last year, Beone Medicines's revenue was $751.65 million.

What was Beone Medicines's revenue in 2024?

Beone Medicines's annual revenue for the twelve months ending Dec 31, 2024 was $3.81 billion, a 54.96% increase year over year.

How much does Beone Medicines make in a day?

Based on Beone Medicines annual revenue for the past five years, ONC makes an average of $5,024,711.23 per day.

What was Beone Medicines's annual revenue growth in the past year?

As of Q2 2025, Beone Medicines's revenue has grown 51.16% year over year. This is 1,309.99 percentage points lower than the US Biotechnology industry revenue growth rate of 1,361.15%. Beone Medicines's revenue in the past year totaled $4.18 billion.

How much does Beone Medicines make in a year?

Beone Medicines's revenue by year for the past five years is:
  • Beone Medicines's revenue for the twelve months ending Dec 31, 2024 was $3.81 billion, a 54.96% increase year over year.
  • Beone Medicines's annual revenue for Dec 31, 2023 was $2.46 billion, a 73.65% increase from 2022.
  • Beone Medicines's annual revenue for 2022 was $1.42 billion, a 20.37% increase from 2021.
  • Beone Medicines's annual revenue for 2021 was $1.18 billion, a 280.83% increase from 2020.
  • Beone Medicines's annual revenue for 2020 was $308.87 million, a 27.87% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.